129 related articles for article (PubMed ID: 17593041)
1. Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.
Rao VS; Jameel JK; Mahapatra TK; McManus PL; Fox JN; Drew PJ
Breast J; 2007; 13(4):368-73. PubMed ID: 17593041
[TBL] [Abstract][Full Text] [Related]
2. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer.
Owusu C; Lash TL; Silliman RA
Breast J; 2007; 13(4):374-82. PubMed ID: 17593042
[TBL] [Abstract][Full Text] [Related]
4. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
[TBL] [Abstract][Full Text] [Related]
5. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
8. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer.
Fennessy M; Bates T; MacRae K; Riley D; Houghton J; Baum M
Br J Surg; 2004 Jun; 91(6):699-704. PubMed ID: 15164437
[TBL] [Abstract][Full Text] [Related]
9. [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?].
Sanguinetti A; Ragusa M; De Falco M; Sperlongano P; Calzolari F; Parmeggiani D; Misso C; Piatto A; Parmeggiani U; Avenia N
Chir Ital; 2007; 59(6):829-33. PubMed ID: 18360988
[TBL] [Abstract][Full Text] [Related]
10. Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.
Livi L; Saieva C; Paiar F; Simontacchi G; Galardi A; De Luca Cardillo C; Mangoni M; Paoletti L; Ponticelli P; Biti GP
Eur J Surg Oncol; 2007 Apr; 33(3):271-5. PubMed ID: 16831531
[TBL] [Abstract][Full Text] [Related]
11. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.
Gazet JC; Ford HT; Coombes RC; Bland JM; Sutcliffe R; Quilliam J; Lowndes S
Eur J Surg Oncol; 1994 Jun; 20(3):207-14. PubMed ID: 8181594
[TBL] [Abstract][Full Text] [Related]
13. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in the elderly: treatment of 1500 patients.
Livi L; Paiar F; Saieva C; Simontacchi G; Nori J; Sanchez L; Santini R; Mangoni M; Fondelli S; Distante V; Bianchi S; Biti G
Breast J; 2006; 12(4):353-9. PubMed ID: 16848846
[TBL] [Abstract][Full Text] [Related]
15. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL
Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574
[TBL] [Abstract][Full Text] [Related]
16. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly.
Mustacchi G; Milani S; Pluchinotta A; De Matteis A; Rubagotti A; Perrota A
Anticancer Res; 1994; 14(5B):2197-200. PubMed ID: 7840523
[TBL] [Abstract][Full Text] [Related]
18. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
19. Tumorectomy plus tamoxifen for the treatment of breast cancer in the elderly.
Dünser M; Häussler B; Fuchs H; Margreiter R
Eur J Surg Oncol; 1993 Dec; 19(6):529-31. PubMed ID: 8270038
[TBL] [Abstract][Full Text] [Related]
20. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
